The tight coupling between such bispecific antibody and the p53 (R175H) peptide-HLA complex on tumor cells and TCR-CD3 complex on T cells ameliorate the hampered immune elimination caused by the original low density of neoantigens. This evidence concerns the gene TP53 and neoplasm.